 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Global Alliance for TB Drug Development |
| Street 1: | 40 Wall Street |
| Street 2: | 24th Floor |
| City: | New York |
| Province: | NY |
| Post Code: | 10005 |
| Country: | United States of America |
| Phone: | 12122277540 |
| Email: | info@tballiance.org |
| Web Site: | http://www.tballiance.org |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Developed Country NGO |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Other Non-Governmental Organization (NGO) |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | International |
| Organization Description: | |
| The TB Alliance is a not-for-profit, product development partnership accelerating the discovery and development of new TB regimens that will shorten treatment, be effective against susceptible and resistant strains, be compatible with antiretroviral therapies for those HIV-TB patients currently on such therapies, and improve treatment of latent infection. The TB Alliance is committed to ensuring that approved new drug regimens are affordable, widely adopted and available to those who need them. |
|
| Total number of staff in your organization: | 26 - 50 |
| Number of full-time staff who are directly involved with TB: | 26 - 50 |
| Number of part-time staff who are directly involved with TB: | 0 |
| Number of volunteers who are directly involved with TB: | 0 |
| What is your organization's annual budget (USD) dedicated to TB? | >$10 MIL |
| How did you hear about the Stop TB Partnership: | Attendance at a TB related event |
| Why do you wish join the Stop TB Partnership: | Other (please explain) |
| Are you a member of a Stop TB national partnership: | United States of America |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Development of new tools for TB is a critical component of the Stop TB Strategy as well as the plan for the elimination of TB in the country our organization is located in. | |
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which WHO region is the main focus of your work: | Global |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
India Ireland Kenya Mexico South Africa United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania United States of America Zambia |
Specializations | |
|
Advocacy, communication and social mobilization Funding Research and Development |
Specializations in Countries | |
| Advocacy, communication and social mobilization | United Kingdom of Great Britain and Northern Ireland |
| Advocacy, communication and social mobilization | United States of America |
| Funding | Ireland |
| Funding | United Kingdom of Great Britain and Northern Ireland |
| Funding | United States of America |
| Research and Development | China |
| Research and Development | India |
| Research and Development | Kenya |
| Research and Development | Mexico |
| Research and Development | South Africa |
| Research and Development | United Republic of Tanzania |
| Research and Development | Zambia |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
Drug-Resistant TB: Development of new TB regimens that will improve the treatment of drug-resistant TB by shortening therapy and making it more affordable. Advocacy efforts to support the development of improved diagnostics. TB-HIV: Development of new TB regimens that are ARV-compatible. Laboratory Strengthening: Capacity building through research and development work New TB Drugs: Development of new TB regimens |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | |
| Last updated: | May 16, 2012 |